Construction, expression, and function of 6B11ScFv-mIL-12, a fusion protein that attacks human ovarian carcinoma

Medical Oncology
Hong-Yan ChengJianli Sang

Abstract

We previously produced an anti-idiotypic monoclonal antibody, 6B11, which mimics ovarian cancer antigen CA166-9 and induces cellular and humoral immunity. Here, to enhance the immunogenicity of 6B11, we constructed the 6B11ScFv-mIL-12 fusion protein (FP), by fusing single-chain fragment of 6B11 variable region (6B11ScFv) with mouse interleukin-12 (mIL-12), which was expressed in eukaryotic 293EBNA cells transfected with pSBI vectors. A binding activity assay showed 6B11ScFv-mIL-12 to have activities of both 6B11 and mIL-12-it specifically bound both ovarian monoclonal antibody COC166-9 and rabbit anti-mouse IL-12 antibody. The immune activity assay showed 6B11ScFv-mIL-12 to promote proliferation of lymphocytes stimulated by phytohemagglutinin, increase the absolute numbers and percentages of CD3(-)/CD56(+) natural killer cells and CD3(+)/CD56(+) natural killer T cells among peripheral lymphocytes, and increase interferon-γ. The FP was specifically cytotoxic to the CA166-9(+) ovarian cancer cell lines HOC1A and SKOV3 and inhibited growth of ID8 subcutaneous tumors in C57BL/6J mice. This study provides an experimental basis for clinical use of 6B11ScFv-mIL-12 in ovarian cancer therapy. To our knowledge, this is the first report o...Continue Reading

References

Mar 12, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Silke ReinartzUwe Wagner
Nov 29, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G ChongJ Carmichael
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles H RedfernJohn F Bender
Sep 28, 2006·Breast Cancer Research and Treatment·Kartik MohantyMalaya Bhattacharya-Chatterjee
Sep 29, 2006·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J PfistererF Hilpert
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gustav J UllenhagLindy G Durrant
Nov 28, 2006·Trends in Immunology·Andrea M Cooper, Shabaana A Khader
May 29, 2007·Oncogene·A López-Díaz de CerioM Bendandi
Dec 14, 2007·Cancer Biology & Therapy·Saily AlfonsoAmparo E Macias
Apr 3, 2008·Seminars in Hematology·Ann S LaCasce, Arnold S Freedman
May 26, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Hiroto KayashimaYoshihiko Maehara
Jun 10, 2010·Cancer Immunology, Immunotherapy : CII·Maha Zohra LadjemiIsabelle Navarro-Teulon
Jun 29, 2010·Cancer Biotherapy & Radiopharmaceuticals·Xiaoling YinHoujie Liang
Nov 5, 2010·Clinical & Developmental Immunology·Luis E FernandezDaniel F Alonso
Sep 20, 2011·Pharmacotherapy·Aimee E HammerstromPadmanee Sharma
Jan 13, 2012·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal

❮ Previous
Next ❯

Citations

Nov 13, 2020·Frontiers in Immunology·Khue G NguyenDavid A Zaharoff

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cell Adhesion Molecules in the Brain

Cell adhesion molecules found on cell surface help cells bind with other cells or the extracellular matrix to maintain structure and function. Here is the latest research on their role in the brain.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.